Veru (VERU) FCF Payout Ratio Growth (1y) (2011 - 2015)
Veru (VERU) FCF Payout Ratio Growth (1y) (2011 - 2015) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 68.88% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -31.89% |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | -100.01% |
| Dec 31, 2014 | -100.23% |
| Sep 30, 2014 | 99.12% |
| Jun 30, 2014 | 3,385.92% |
| Dec 31, 2013 | 1.46% |
| Sep 30, 2013 | 60.75% |
| Jun 30, 2013 | -64.39% |
| Mar 31, 2013 | 1,890.18% |
| Dec 31, 2012 | -6.54% |
| Sep 30, 2012 | -97.97% |
| Jun 30, 2012 | -55.80% |
| Dec 31, 2011 | 458,019.13% |
| Sep 30, 2011 | 63.11% |